Ledger.Open graph →
SEC Form D · filed March 9, 2020

Redpin Therapeutics, Inc

Offering
$30.0M
Sold
$7.8M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
NEW YORK, NY
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (3)

Elma Hawkins · New York, NYExec · DirectorJustin Ehrlich · Los Angeles, CAExec · DirectorHussein Kanji · London, United KingdomExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗